About Arch Biopartners

What does Arch Biopartners do?

Arch Biopartners is a provider of product acquisition and development for sale to pharmaceutical and industrial companies, with a focus on LSALT peptide (Metablok), a drug candidate that inhibits DPEP1 to target acute organ inflammation in the lungs, liver, and kidneys, including a Phase II international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide for cardiac surgery–associated acute kidney injury.

Who are Arch Biopartners's competitors?

Arch Biopartners's competitors and similar companies include KAI Pharmaceuticals, Ablynx, Restorbio, Salubris, and Endacea.

Where is Arch Biopartners headquartered?

Arch Biopartners is headquartered in Canada.

How many employees does Arch Biopartners have?

Arch Biopartners has 1,000 employees 🔒.

When was Arch Biopartners founded?

Arch Biopartners was founded in 2010 🔒.

What sector and industry vertical is Arch Biopartners in?

Arch Biopartners is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Arch Biopartners

Who are the top strategic acquirers in Arch Biopartners's sector and industry

Top strategic M&A buyers and acquirers in Arch Biopartners's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Arch Biopartners?

Top strategic M&A buyers groups and sectors for Arch Biopartners include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Arch Biopartners's sector and industry vertical

Which are the top PE firms investing in Arch Biopartners's sector and industry vertical?

Top PE firms investing in Arch Biopartners's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Arch Biopartners's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Arch Biopartners's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Arch Biopartners's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Arch Biopartners include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Arch Biopartners's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Arch Biopartners?

The key public trading comparables and valuation benchmarks for Arch Biopartners include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Arch Biopartners for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Arch Biopartners with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Arch Biopartners's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Arch Biopartners with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Arch Biopartners's' sector and industry vertical?

Access recent funding rounds and capital raises in Arch Biopartners's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.